K J Olsen

665 citations
9 papers · 540 indexed · h-index 9
Topics
Virus-based gene therapy research (3 papers)CAR-T cell therapy research (2 papers)RNA Interference and Gene Delivery (2 papers)

In The Last Decade

K J Olsen

9 papers receiving 533 citations

Peers

K J Olsen
Comparison fields: 5 of 79
  • Immunology 302
  • Molecular Biology 159
  • Oncology 86
  • Hematology 67
  • Infectious Diseases 44
Replace Ryan Schlimgen with:
Ryan Schlimgen United States
Connie Clark United States
Arnika Rehbein Germany
Vijay Kuchroo United States
SH Ip United States
Eva M. Briso United States
F Le Deist France
Ursula Holzer Germany
Thomas M. Yankee United States
K Lorré Belgium
K J Olsen relative to Ryan Schlimgen United States Ryan Schlimgen's profile →
Citations per field
00.5×1.7×
Ryan Schlimgen · 1×
Citations per year

Countries citing papers authored by K J Olsen

Since Specialization
Citations

This map shows the geographic impact of K J Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K J Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K J Olsen more than expected).

Fields of papers citing papers by K J Olsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K J Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K J Olsen. The network helps show where K J Olsen may publish in the future.

Co-authorship network of co-authors of K J Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of K J Olsen. A scholar is included among the top collaborators of K J Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K J Olsen. K J Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 34
2 152
3
Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
12
4 50
5 67
6 53
7
Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody.
53
8 88
9 31

About K J Olsen

K J Olsen is a scholar working on Immunology, Hematology and Biotechnology, having authored 9 papers that have together received 540 indexed citations. Recurring topics across this work include Virus-based gene therapy research (3 papers), CAR-T cell therapy research (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (302 citations), Hematology (67 citations) and Dermatology (32 citations). K J Olsen has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Eckhard R. Podack, Danyang Zhao, R K Lee, J Spielman, A Hameed, Mathias G. Lichtenheld, Michael K. Lee, Ling Cheng, D Avila and Michael A. Bowen. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026